Naratriptan

Back to search

Molecule Structure

Scientific Name

Naratriptan

Description of the Drug

Naratriptan is a 5-HT1B/1D receptor agonist used to treat migraines.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00952

Brand Name(s)

Amerge, Naratriptan

Company Owner(s)

Apotex Corp, Padagis Us Llc, Sun Pharmaceutical Industries Ltd, Chartwell Rx Sciences Llc, Ani Pharmaceuticals Inc, Orbion Pharmaceuticals Private Ltd, Mylan Pharmaceuticals Inc, Glaxosmithkline Llc, Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc, Hikma Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Serotonin 1b (5-HT1b) receptor SINGLE PROTEIN AGONIST CHEMBL1898
Serotonin 1d (5-HT1d) receptor SINGLE PROTEIN AGONIST CHEMBL1983

Unichem Links

SureChEMBL SCHEMBL68753
PharmGKB PA450597
Human Metabolome Database HMDB0015087
DrugBank DB00952
PubChem: Thomson Pharma 14802133
PubChem 4440
NMRShiftDB 10021715
Nikkaji J550.688C
BindingDB 50073682
EPA CompTox Dashboard DTXSID7023354
DrugCentral 1884
ChemicalBook CB1874790
Guide to Pharmacology 45
rxnorm NARATRIPTAN HYDROCHLORIDE AMERGE NARATRIPTAN
KEGG Ligand C07792
ChEBI 7478
ZINC ZINC000000004076